1. |
Outline of the counterparty to this agreement
|
(1)
|
Name
|
Jiangsu WangaoPharmaceutical Co., Ltd.
| |||
(2)
|
Adress
|
No. 688 Dinghai Road, Haimen Economic and Technological Development Zone, Nantong, Jiangsu Province
| |||
(3)
|
Title and name of the representative
|
Junhua Yao
| |||
(4)
|
Business
|
Research, development and manufacture of pharmaceutical products
| |||
(5)
|
Capital stock
|
Not available due to confidentiality agreement
|
(6)
|
Date of Establishment
|
2003
| |||||
(7)
|
Major Shareholders and Shareholding Ratio
|
Not available due to confidentiality agreement
| |||||
(8)
|
The relationship between the counterparty and the Company
|
Capital relationships
|
Not applicable.
| ||||
Human resource relationships
|
Not applicable.
| ||||||
Business relationships
|
Not applicable.
| ||||||
Related Party Status
|
Not applicable.
| ||||||
(9)
|
The operating results and financial positions of the counterparty in the last 3 years
|
Not available due to confidentiality agreement
|
2. |
Date
|
(1)
|
Date of BOD resolution
|
May 7, 2024
| |||
(2)
|
Date of conclusion
|
May 7, 2024
| |||
(3)
|
Date of commencement of sales
|
To be determined upon consultation between the parties
|
3. |
Forecasts
|
Attachments
- Original Link
- Permalink
Disclaimer
Catalyst Biosciences Inc. published this content on 08 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 May 2024 12:02:03 UTC.